Basile Jeff, Thiers Bruce, Maize John, Lathers Deanne M R
Department of Graduate Studies, Medical University of South Carolina, College of Medicine, USA.
J Cutan Pathol. 2008 Jul;35(7):623-9. doi: 10.1111/j.1600-0560.2007.00879.x. Epub 2008 Feb 29.
Previous studies suggest that chemokines and chemokine receptors have a role in the metastatic process. A correlation exists between the specific expression of these chemoattractive, pro-inflammatory cytokines and the ability of cancer to disseminate. Prior studies have shown that in metastatic melanoma and squamous cell carcinoma of the head and neck upregulation of CXC (alpha) chemokine receptor (CXCR)4 and CC (beta) chemokine receptor (CCR)7 expression is accompanied by downregulation of the chemokine receptor CCR6. However, the expression patterns of CCR6, CCR7 and CXCR4 in non-melanoma skin cancer have yet to be elucidated.
The expression patterns of CCR6, CCR7 and CXCR4 were determined using an immunohistochemical approach on formalin-fixed, paraffin-embedded normal, pre-cancerous actinic (solar) keratosis, squamous cell carcinoma and basal cell carcinoma tissues.
Analysis of chemokine receptor expression showed downregulation of CCR6 and upregulation of CCR7 and CXCR4 in potentially metastatic non-melanoma skin cancer, invasive squamous cell carcinoma, but this pattern did not exist in non-melanoma skin cancer with no metastatic potential, basal cell carcinoma; or actinic keratosis, when compared with normal skin.
Chemokine receptor expression may influence the biological behavior of non-melanoma skin cancer. The exact mechanism by which this occurs requires further study.
先前的研究表明趋化因子和趋化因子受体在转移过程中发挥作用。这些具有趋化作用的促炎细胞因子的特异性表达与癌症的扩散能力之间存在相关性。先前的研究表明,在转移性黑色素瘤以及头颈部鳞状细胞癌中,CXC(α)趋化因子受体(CXCR)4和CC(β)趋化因子受体(CCR)7表达上调,同时趋化因子受体CCR6表达下调。然而,非黑色素瘤皮肤癌中CCR6、CCR7和CXCR4的表达模式尚未阐明。
采用免疫组织化学方法,对福尔马林固定、石蜡包埋的正常组织、癌前光化性(日光性)角化病组织、鳞状细胞癌组织和基底细胞癌组织中CCR6、CCR7和CXCR4的表达模式进行测定。
趋化因子受体表达分析显示,在具有潜在转移能力的非黑色素瘤皮肤癌、浸润性鳞状细胞癌中,CCR6表达下调,CCR7和CXCR4表达上调,但与正常皮肤相比,在无转移潜能的非黑色素瘤皮肤癌(基底细胞癌)或光化性角化病中不存在这种模式。
趋化因子受体表达可能影响非黑色素瘤皮肤癌的生物学行为。其发生的确切机制需要进一步研究。